Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beth A Helmink

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Annual Review of Immunology|January 10, 2012
The response to and repair of RAG-mediated DNA double-strand breaksBeth A Helmink, Barry P Sleckman
Annals of Surgical Oncology|November 21, 2025
ASO Author Reflections: An Evolving Understanding of High-Grade Appendiceal Mucinous NeoplasmsAshlee N Seldomridge, Beth A Helmink
JAMA|May 12, 2025
The Microbiome and Cancer: A Translational Science ReviewEstefania Fernandez, Jennifer A Wargo, Beth A Helmink
Annals of Surgical Oncology|November 17, 2021
Biomarker-Driven Prognostication in Merkel Cell Carcinoma: A Paradigm for Personalized TherapyBeth A Helmink, George Ansstas, Ryan C Fields
Immunity|June 21, 2018
Immune Checkpoint Blockade across the Cancer Care ContinuumBeth A Helmink, Pierre-Olivier Gaudreau, Jennifer A Wargo
Cell|October 8, 2021
Hallmarks of response, resistance, and toxicity to immune checkpoint blockadeGolnaz Morad, Beth A Helmink, Padmanee Sharma, et al.
Cell|February 5, 2022
Hallmarks of response, resistance, and toxicity to immune checkpoint blockadeGolnaz Morad, Beth A Helmink, Padmanee Sharma, et al.
Annals of Surgical Oncology|January 23, 2020
Toxicity of Immune Checkpoint Inhibitors: Considerations for the SurgeonBeth A Helmink, Christina L Roland, Colleen M Kiernan, et al.
The Lancet. Oncology|February 5, 2019
Modulating the microbiome to improve therapeutic response in cancerJennifer L McQuade, Carrie R Daniel, Beth A Helmink, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 10, 2023
TIME for Bugs: The Immune Microenvironment and Microbes in PrecancerMikayla Borthwick Bowen, Beth A Helmink, Jennifer A Wargo, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Annual Review of Immunology|January 10, 2012
The response to and repair of RAG-mediated DNA double-strand breaksBeth A Helmink, Barry P Sleckman
Annals of Surgical Oncology|November 21, 2025
ASO Author Reflections: An Evolving Understanding of High-Grade Appendiceal Mucinous NeoplasmsAshlee N Seldomridge, Beth A Helmink
JAMA|May 12, 2025
The Microbiome and Cancer: A Translational Science ReviewEstefania Fernandez, Jennifer A Wargo, Beth A Helmink
Annals of Surgical Oncology|November 17, 2021
Biomarker-Driven Prognostication in Merkel Cell Carcinoma: A Paradigm for Personalized TherapyBeth A Helmink, George Ansstas, Ryan C Fields
Immunity|June 21, 2018
Immune Checkpoint Blockade across the Cancer Care ContinuumBeth A Helmink, Pierre-Olivier Gaudreau, Jennifer A Wargo
Cell|October 8, 2021
Hallmarks of response, resistance, and toxicity to immune checkpoint blockadeGolnaz Morad, Beth A Helmink, Padmanee Sharma, et al.
Cell|February 5, 2022
Hallmarks of response, resistance, and toxicity to immune checkpoint blockadeGolnaz Morad, Beth A Helmink, Padmanee Sharma, et al.
Annals of Surgical Oncology|January 23, 2020
Toxicity of Immune Checkpoint Inhibitors: Considerations for the SurgeonBeth A Helmink, Christina L Roland, Colleen M Kiernan, et al.
The Lancet. Oncology|February 5, 2019
Modulating the microbiome to improve therapeutic response in cancerJennifer L McQuade, Carrie R Daniel, Beth A Helmink, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 10, 2023
TIME for Bugs: The Immune Microenvironment and Microbes in PrecancerMikayla Borthwick Bowen, Beth A Helmink, Jennifer A Wargo, et al.
Pageof 5